Literature DB >> 16911355

Associations between antioxidant status, markers of oxidative stress and immune responses in allergic adults.

J A Dunstan1, L Breckler, J Hale, H Lehmann, P Franklin, G Lyons, G Lyonso, S Y L Ching, T A Mori, A Barden, S L Prescott.   

Abstract

BACKGROUND: There has been growing interest in the role of antioxidant function in controlling inflammatory disease states, such as allergy. This study investigated the relationship between antioxidant status, markers of airways inflammation [exhaled nitric oxide (eNO)], oxidative stress (F(2) isoprostanes) and immune responses in allergic adults.
METHODS: Antioxidants (vitamins C, E, beta-carotene and selenium) and total antioxidant capacity (tAC) in serum were examined in relation to eNO, plasma F(2) isoprostanes and peripheral blood mononuclear cell (PBMC) cytokine and lymphoproliferative response to house dust mite (HDM) allergen, Staphylococcus enterotoxin B (SEB), phytohaemaglutinin (PHA) and lipopolysaccharide (LPS) in 54 allergic adults.
RESULTS: Firstly, levels of specific vitamins did not correlate with tAC. Secondly, we did not see any evidence that specific vitamin levels (or tAC) were associated with either polarization or attenuation of in vitro immune responses. If anything, there were positive correlations between antioxidant (vitamin C and selenium) levels and HDM allergen responses [lymphoproliferation (selenium; r=0.35, P=0.013) and both Th2 IL13 (vitamin C; tau=0.254, P=0.028) and Th1 IFN-gamma (vitamin C; tau=0.302, P=0.009) responses]. There were also significant positive relationships between antioxidant levels and IL-10 responses to polyclonal stimulation by SEB (r=0.292, P=0.036) and LPS (r=0.34, P=0.015) (beta-carotene) and PHA (r=0.34, P=0.021) (tAC). Thirdly, although airways inflammation (eNO) was associated with both in vitro and in vivo (skin test reactivity) to HDM, we did not see any correlation between eNO and oxidative stress (F(2)-isoprostanes). Finally, there were no consistent relationships between oxidative stress and immune responses.
CONCLUSION: There was no evidence that higher antioxidant levels were associated with reduced allergen responsiveness in allergic adults. If anything, antioxidant status was associated with increased immune responsiveness. The significance of this needs to be addressed in future intervention studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911355     DOI: 10.1111/j.1365-2222.2006.02539.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

Review 1.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

Review 2.  Selenium and asthma.

Authors:  Robert L Norton; Peter R Hoffmann
Journal:  Mol Aspects Med       Date:  2011-10-15

3.  Biomarkers of oxidative stress study VI. Endogenous plasma antioxidants fail as useful biomarkers of endotoxin-induced oxidative stress.

Authors:  Maria B Kadiiska; Shyamal Peddada; Ronald A Herbert; Samar Basu; Kenneth Hensley; Dean P Jones; Gary E Hatch; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2015-01-19       Impact factor: 7.376

4.  Nutrient intake and immune function of elderly subjects.

Authors:  Laura Wardwell; Karen Chapman-Novakofski; Susan Herrel; Jeffrey Woods
Journal:  J Am Diet Assoc       Date:  2008-12

5.  25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation.

Authors:  Nan Lan; Guangyan Luo; Xiaoqiong Yang; Yuanyuan Cheng; Yun Zhang; Xiaoyun Wang; Xing Wang; Tao Xie; Guoping Li; Zhigang Liu; Nanshan Zhong
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

6.  Complex effects of vitamin E and vitamin C supplementation on in vitro neonatal mononuclear cell responses to allergens.

Authors:  Heather J H Wassall; Graham Devereux; Anthony Seaton; Robert N Barker
Journal:  Nutrients       Date:  2013-08-26       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.